Atria Wealth Solutions, Inc. Bristol Myers Squibb CO Transaction History
Atria Wealth Solutions, Inc.
- $4.15 Billion
- Q2 2025
A detailed history of Atria Wealth Solutions, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Atria Wealth Solutions, Inc. holds 57,977 shares of BMY stock, worth $2.59 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
57,977
Previous 161,837
64.18%
Holding current value
$2.59 Million
Previous $9.87 Million
72.82%
% of portfolio
0.06%
Previous 0.13%
Shares
18 transactions
Others Institutions Holding BMY
# of Institutions
2,677Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.71 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.09 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.83 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.23 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.16 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $95B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...